Australian & New Zealand Childrens Haematology/Oncology Group
Study Title
Risk-stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
Protocol ID
AAML1531
Disease (Sub Disease)
Leukaemia
Diagnosis Stage
New diagnosis
Location
NSW, VIC, WA, NZ
Sponsor
Children's Oncology Group
Collaborators
National Cancer Institute (NCI)
Links
Trial Status
Open
Sites
The Children's Hospital at Westmead
John Hunter Children's Hospital
Perth Children's Hospital
Sydney Children's Hospital
Royal Children's Hospital
Christchurch Hospital
Starship Hospital
John Hunter Children's Hospital
Perth Children's Hospital
Sydney Children's Hospital
Royal Children's Hospital
Christchurch Hospital
Starship Hospital
Study Type
Treatment
Phase
Phase 3
Age Eligibility
90 days to 4 years
International registry ID's
NCT02521493
| Study Title | Risk-stratified Therapy for Acute Myeloid Leukemia in Down Syndrome |
|---|---|
| Protocol ID | AAML1531 |
| Disease (Sub Disease) | Leukaemia |
| Diagnosis Stage | New diagnosis |
| Location | NSW / VIC / WA / NZ |
| Sponsor | Children's Oncology Group |
| Collaborators | National Cancer Institute (NCI) |
| Links | https://clinicaltrials.gov/ct2/show/NCT02521493 |
| Trial Status | Open |
| Trial Open Date | 03/11/2015 |
| Sites | The Children's Hospital at Westmead / John Hunter Children's Hospital / Perth Children's Hospital / Sydney Children's Hospital / Royal Children's Hospital / Christchurch Hospital / Starship Hospital/ |
| Study Type | Treatment |
| Phase | Phase 3 |
| Age Eligibility | 90 days to 4 years |
| International registry ID's | NCT02521493 |